GLICLAZIDE SANDOZ
As listed in the register: GLICLAZIDE SANDOZ 30 mg, comprimé à libération modifiée
30 mg · comprimé à libération modifiée
- Prescription only
- Active substance
- Gliclazide
- Made by
- SANDOZ
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
Bulgaria5 matching products
Canada8 matching products
- AG-GLICLAZIDE MR 30 mg · tablet (extended-release)
- APO-GLICLAZIDE MR 30 mg · tablet (extended-release)
- DIAMICRON MR 30 mg · tablet (extended-release)
- GLICLAZIDE MR TABLETS 30 mg · tablet (extended-release)
- JAMP GLICLAZIDE-MR 30 mg · tablet (extended-release)
- MINT-GLICLAZIDE MR 30 mg · tablet (extended-release)
- MYLAN-GLICLAZIDE MR 30 mg · tablet (extended-release)
- TARO-GLICLAZIDE MR 30 mg · tablet (extended-release)
Netherlands9 matching products
- Gliclazide retard Teva 30 mg 30 mg · tablet met gereguleerde afgifte2 makers
- DIAMICRON MR 30 mg 30 mg · tablet met gereguleerde afgifte
- Gliclazide 30 mg PCH 30 mg · tablet met gereguleerde afgifte
- Gliclazide Aurobindo Retard 30 mg 30 mg · tablet met gereguleerde afgifte
- Gliclazide Brillpharma 30 mg 30 mg · tablet met verlengde afgifte
- Gliclazide Retard Viatris 30 mg 30 mg · tablet met gereguleerde afgifte
- Gliclazide Sandoz 30 mg 30 mg · tablet met gereguleerde afgifte
- Gliclazide Sandoz retard 30 mg 30 mg · tablet met verlengde afgifte
Details
| Made by | SANDOZ |
|---|---|
| Active substance | Gliclazide |
| Strength | 30 mg |
| Form | comprimé à libération modifiée |
| Route | orale |
| Dispensing (as stated by the register) | liste I |
| Marketed | Yes, according to the register |
| Authorisation procedure | Procédure décentralisée |
| Name in the register | GLICLAZIDE SANDOZ 30 mg, comprimé à libération modifiée |
| Packs | plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 30 comprimé(s) · plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 60 comprimé(s) · plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 180 comprimé(s) |
| CIS | 66496173 |
| CIP13 | 3400930171127 |
| CIP13 | 3400930171158 |
| CIP13 | 3400930171202 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).
Other strengths and forms
3 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.